titoli, abstracts, parole chiave >>>
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes

Maida, Ivana Rita and Martín Carbonero, Luz and Sotgiu, Giovanni and Vispo, Maria Eugenia and Barreiro, Pablo and Gonzalez-Lahoz, Juan and Soriano, Vincent (2010) Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes. Journal of Viral Hepatitis, Vol. 17 (12), p. 866-871. eISSN 1365-2893. Article.

Full text not available from this repository.

DOI: 10.1111/j.1365-2893.2009.01260.x

Abstract

Severity of liver fibrosis and response to pegylated interferon plus ribavirin (pegIFN–RBV) are not well known in HIV/HCV-coinfected patients with persistently normal alanine aminotransferase (PNALT). All HIV/HCV-coinfected patients who had been assessed for liver fibrosis using elastometry during 2005 at our clinic were evaluated. Those with at least 1 year with three prior consecutive ALT measurements below the upper limit of normality were compared with patients with elevated ALT. Response to pegIFN–RBV was assessed in a subset of these patients. We analysed 87 patients with PNALT and 122 with elevated ALT. Compared to patients with elevated ALT, those with PNALT were significantly more often women (42% vs 26%), had greater mean CD4 counts (565 vs 420 cells/mm3), had lower mean serum HCV-RNA (5.8 vs 6.2 log IU/ml) and were infected by HCV genotype 4 (33% vs 6%). Liver fibrosis was considered as severe (Metavir F3) in 10% of patients with PNALT, and another 4% had cirrhosis based on stiffness values. These numbers were 16% and 35% in patients with elevated ALT. Treatment with pegIFN–RBV was given to 22 and 45 patients with PNALT and elevated ALT, respectively. Sustained virological response was achieved in 50% and 29% of them. In the multivariate analysis, PNALT was independently associated with response (OR: 7.9; 95% CI: 1.4–45.2; P = 0.02). Nearly 15% of HIV/HCV-coinfected patients with PNALT showed advanced liver fibrosis (Metavir F3-F4 estimates by elastometry). In summary, response to pegIFN–RBV is higher in patients with PNALT than in those with elevated ALT. Therefore, treatment should not be denied in HIV/HCV-coinfected patients with PNALT.

Item Type:Article
ID Code:5922
Status:Published
Refereed:Yes
Uncontrolled Keywords:Hepatitis C, HIV, interferon, liver, normal liver enzymes, ribavirin
Subjects:Area 06 - Scienze mediche > MED/17 Malattie infettive
Divisions:001 Università di Sassari > 01 Dipartimenti > Scienze biomediche
001 Università di Sassari > 03 Istituti > Malattie infettive e parassitarie
Publisher:Blackwell / Wiley
eISSN:1365-2893
Deposited On:13 Apr 2011 10:42

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page